SCHEMBL3293807

SCHEMBL3293807

c1ccc([Si](c2ccccc2)(c2ccccc2)c2ccc(-c3ccccc3-c3ccc([Si](c4ccccc4)(c4ccccc4)c4ccccc4)cc3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ HPGD P15428 1/20 0.39
▸ BCL2L1 Q07817 1/20 0.39
▸ CYP2A6 P11509 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ ABL1 P00519 2/20 0.38
▸ ABCB1 P08183 2/20 0.38
▸ BCR P11274 2/20 0.38
▸ GPR55 Q9Y2T6 1/20 0.38
▸ DCUN1D1 Q96GG9 2/20 0.36
▸ NISCH Q9Y2I1 1/20 0.36
▸ APP P05067 1/20 0.36
▸ CASP3 P42574 1/20 0.35
▸ SENP8 Q96LD8 1/20 0.35
▸ SENP7 Q9BQF6 1/20 0.35
▸ SENP6 Q9GZR1 1/20 0.35
▸ BACE1 P56817 1/20 0.35
▸ ESR1 P03372 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29849782 0.97 PTGS2 (0.43) PTGS2ALDH1A1HSD17B10HPGDBCL2L1
SCHEMBL13295272 0.86 ALDH1A1 (0.33) PTGS2ALDH1A1HSD17B10HPGDBCL2L1
SCHEMBL15975759 0.86 ALDH1A1 (0.47) PTGS2ALDH1A1HSD17B10BCL2L1MAPK1
SCHEMBL2005519 0.86 ALDH1A1 (0.47) PTGS2ALDH1A1HSD17B10BCL2L1MAPK1
SCHEMBL3292244 0.86 ALDH1A1 (0.47) PTGS2ALDH1A1HSD17B10BCL2L1MAPK1
SCHEMBL21766542 0.84 ALDH1A1 (0.64) ALDH1A1HSD17B10HPGDDCUN1D1
SCHEMBL30713831 0.84 MAPK1 (0.64) ALDH1A1HSD17B10HPGDMAPK1DCUN1D1
SCHEMBL20955829 0.84 IDO1 (0.36) PTGS2ALDH1A1HSD17B10HPGDBCL2L1
SCHEMBL20226006 0.84 ALDH1A1 (0.36) PTGS2ALDH1A1HSD17B10HPGDBCL2L1
SCHEMBL9319701 0.83 ALDH1A1 (0.53) PTGS2ALDH1A1HSD17B10BCL2L1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7728138-B2 Bis-triphenylsilyl compounds and their application on organic electronic device NATIONAL TSING HUA UNIVERSITY (TW) 2010-06-01 — — US disclosed
US-7728138-B2 Bis-triphenylsilyl compounds and their application on organic electronic device NATIONAL TSING HUA UNIVERSITY (TW) 2010-06-01 — — US disclosed
US-20090131670-A1 charge transfer; light emitters; electroluminesence, phosphorescence Cheng, Chien-Hong (TW) 2009-05-21 — — US disclosed
US-20090131670-A1 charge transfer; light emitters; electroluminesence, phosphorescence Cheng, Chien-Hong (TW) 2009-05-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131670-A1 charge transfer; light emitters; electroluminesence, phosphorescence CCNT1, CCNE2, CCNT2 PTGS2 1842/4885ALDH1A1 2933/4885HSD17B10 4214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback